Northwest Biotherapeutics
OTC: NWBOBethesda, US · Delaware corporation · 2 known investors
Find your way into Northwest Biotherapeutics
NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.
Founders & leadership
AL
Alton L. BoyntonCo-founder & Chief Scientific Officer
MB
Marnix BoschinChief Technical Officer
LG
Leslie GoldmanExecutive
LP
Linda PowersinCEOformer
LF
Linda F. PowersinCEOformer
Board
NM
Navid MalikBoard director
JJ
Jerry JasinowskiBoard director
JC
J Cofer BlackBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 3 of 5 rounds · 2016–2026
▶$2.6MofferedSep 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.6MofferedSep 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jerry J JasinowskiDirector
- Leslie J GoldmanExecutive Officer
- J Cofer BlackDirector
- Navid MalikDirector
- Alton BoyntonExecutive Officer, Director
- Marnix L BoschExecutive Officer
- Linda F PowersExecutive Officer, Director
- Offering amount
- $2.6M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$880KraisedJan 2018 · BiotechnologyRule 506(c)
▶$880KraisedJan 2018 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Linda F PowersExecutive Officer, Director
- Navid MalikDirector
- Marnix BoschExecutive Officer
- Jerry JasinowskiDirector
- Leslie GoldmanExecutive Officer
- J Cofer BlackDirector
- Alton L BoyntonExecutive Officer, Director
- Amount sold
- $880K
- Minimum investment
- $10K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$52KraisedMay 2017 · 1 investors · BiotechnologyRule 506(b)
▶$52KraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J Cofer BlackDirector
- Robert A FarmerDirector
- Jerry JasinowskiDirector
- Navid MalikDirector
- Leslie GoldmanExecutive Officer
- Alton L BoyntonExecutive Officer, Director
- Linda F PowersExecutive Officer, Director
- Amount sold
- $52K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMar 2016 · 5 investors · BiotechnologyRule 506(b)
▶$10MraisedMar 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cofer BlackDirector
- Navid MalikDirector
- Alton L. BoyntonExecutive Officer, Director
- Susan BayhDirector
- Linda F. PowersExecutive Officer, Director
- Jerry JasinowskiDirector
- Robert A. FarmerDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $595.4K
- Sales commissions
- $700K
- Placement agents
- H.C. Wainwright
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Robinhood93 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Bioworld85 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Seeking Alpha73 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Northwest Biotherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Understanding IHub And NWBO: A Comprehensive Guide To Biotech Investment And Information Hubs - Entrepreneurs' Organizationcontracts.eonetwork.org · Aug 2026Frequently asked questions
- What does Northwest Biotherapeutics do?
- NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.
- Who founded Northwest Biotherapeutics?
- Northwest Biotherapeutics was founded by Alton L. Boynton.
- Who are Northwest Biotherapeutics's investors?
- Northwest Biotherapeutics's investors include Vedanta Capital, Yorkville Advisors.
- How much funding has Northwest Biotherapeutics raised?
- Northwest Biotherapeutics has disclosed $10.9M raised across 3 of its 5 known rounds.
- Where is Northwest Biotherapeutics headquartered?
- Northwest Biotherapeutics is headquartered in Bethesda, US.